D-普萘洛尔和DL-普萘洛尔均可降低L-甲状腺素向L-三碘甲状腺原氨酸的转化。
D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.
作者信息
Heyma P, Larkins R G, Higginbotham L, Ng K W
出版信息
Br Med J. 1980 Jul 5;281(6232):24-5. doi: 10.1136/bmj.281.6232.24.
Abstract
The effects of propranolol (DL-propranolol) and D-propranolol on thyroid hormone metabolism were studied in six euthyroid volunteers receiving L-thyroxine (T4) and six hypothyroid patients receiving T4 replacement. D-propranolol as well as propranolol decreased L-triiodothyronine (T3) concentrations and the ratio of T3 to T4 in the euthyroid subjects, and D-propranolol decreased these variables in the subjects with hypothyroidism (propranolol was not given to this group). It is concluded from this study and from parallel invitro investigations that the effect of propranolol on the conversion of T4 to T3 is unrelated to its beta-adrenergic blocking activity, and that at low therapeutic doses propranolol may exert appreciable "membrane-stabilising" effects in vivo.
摘要
在6名接受左旋甲状腺素（T4）的甲状腺功能正常志愿者和6名接受T4替代治疗的甲状腺功能减退患者中，研究了普萘洛尔（DL-普萘洛尔）和D-普萘洛尔对甲状腺激素代谢的影响。D-普萘洛尔以及普萘洛尔降低了甲状腺功能正常受试者的L-三碘甲状腺原氨酸（T3）浓度和T3与T4的比值，D-普萘洛尔降低了甲状腺功能减退受试者的这些变量（该组未给予普萘洛尔）。从这项研究以及平行的体外研究得出结论，普萘洛尔对T4向T3转化的作用与其β-肾上腺素能阻断活性无关，并且在低治疗剂量下，普萘洛尔可能在体内发挥明显的“膜稳定”作用。
相似文献
1
D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.D-普萘洛尔和DL-普萘洛尔均可降低L-甲状腺素向L-三碘甲状腺原氨酸的转化。
Br Med J. 1980 Jul 5;281(6232):24-5. doi: 10.1136/bmj.281.6232.24.
2
The influence of propranolol on the extrathyroidal metabolism of 3,3',5'-triiodothyronine (reverse T3).
Acta Med Scand Suppl. 1979;624:31-34. doi: 10.1111/j.0954-6820.1979.tb00715.x.
3
Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.普萘洛尔、三碘甲状腺原氨酸、反三碘甲状腺原氨酸与甲状腺疾病
Clin Endocrinol (Oxf). 1979 May;10(5):531-8. doi: 10.1111/j.1365-2265.1979.tb02111.x.
4
Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.人体甲状腺素缺乏状态下维持血清三碘甲状腺原氨酸值的外周组织机制。
J Clin Invest. 1984 Feb;73(2):570-5. doi: 10.1172/JCI111245.
5
Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.血清三碘甲状腺原氨酸与甲状腺素比值所反映的甲状腺疾病中的甲状腺激素代谢
J Endocrinol Invest. 1986 Oct;9(5):407-12. doi: 10.1007/BF03346952.
6
The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects.普萘洛尔对甲状腺毒症和甲状腺功能正常受试者循环甲状腺激素测定的影响。
Acta Endocrinol (Copenh). 1985 Mar;108(3):351-5. doi: 10.1530/acta.0.1080351.
7
Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man.甲状腺功能亢进症患者、左甲状腺素治疗的黏液性水肿患者及正常人在使用普萘洛尔治疗期间的血清总甲状腺素（T4）、总三碘甲状腺原氨酸（T3）和反三碘甲状腺原氨酸（rT3）
Horm Metab Res. 1979 Jan;11(1):34-6. doi: 10.1055/s-0028-1092678.
8
Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.测定犬血清总甲状腺素、三碘甲状腺原氨酸、游离甲状腺素和促甲状腺激素浓度以诊断犬甲状腺功能减退症。
J Am Vet Med Assoc. 1997 Dec 1;211(11):1396-402.
9
Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kinetics.通过非房室动力学评估普萘洛尔对甲状腺素和3,3',5-三碘甲状腺原氨酸甲状腺外代谢的影响。
J Clin Endocrinol Metab. 1978 Sep;47(3):587-9. doi: 10.1210/jcem-47-3-587.
10
The effect of prednisone on serum thyrotropin, thyroxine and triiodothyronine concentrations in hypothyroid patients.泼尼松对甲状腺功能减退患者血清促甲状腺激素、甲状腺素和三碘甲状腺原氨酸浓度的影响。
J Endocrinol Invest. 1978 Apr;1(2):171-3. doi: 10.1007/BF03350367.
引用本文的文献
1
Management Aspects of Medical Therapy in Graves Disease.格雷夫斯病的药物治疗管理方面
Endocr Pract. 2025 Apr;31(4):536-546. doi: 10.1016/j.eprac.2024.12.012. Epub 2024 Dec 17.
2
Clinical Review and Update on the Management of Thyroid Storm.甲状腺危象的临床评估及处理更新
Mo Med. 2022 Jul-Aug;119(4):366-371.
3
Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux.普萘洛尔通过改变溶酶体药物隔离和药物外排使血管肉瘤细胞对阿霉素敏感。
Front Oncol. 2021 Feb 1;10:614288. doi: 10.3389/fonc.2020.614288. eCollection 2020.
4
Stereoisomers and drug toxicity. The value of single stereoisomer therapy.立体异构体与药物毒性。单一立体异构体疗法的价值。
Drug Saf. 1993 Feb;8(2):149-59. doi: 10.2165/00002018-199308020-00005.
5
Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.普萘洛尔和美托洛尔在甲状腺功能亢进患者中的作用及血药浓度
Eur J Clin Pharmacol. 1980 Oct;18(4):315-20. doi: 10.1007/BF00561388.
6
Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients.阿替洛尔对甲状腺功能亢进患者血清甲状腺激素的急性影响。
J Endocrinol Invest. 1982 Jan-Feb;5(1):39-41. doi: 10.1007/BF03350480.
7
Pharmacokinetics of propranolol and sotalol in hyperthyroidism.普萘洛尔和索他洛尔在甲状腺功能亢进症中的药代动力学。
Eur J Clin Pharmacol. 1982;21(5):373-7. doi: 10.1007/BF00542321.
8
Effects of antihypertensive drugs on endocrine function.抗高血压药物对内分泌功能的影响。
Drugs. 1984 May;27(5):447-58. doi: 10.2165/00003495-198427050-00004.
9
Use of beta-adrenoceptor blocking drugs in hyperthyroidism.β-肾上腺素能受体阻断药在甲状腺功能亢进症中的应用。
Drugs. 1984 May;27(5):425-46. doi: 10.2165/00003495-198427050-00003.
10
Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.β-肾上腺素受体阻断药在甲状腺疾病中的临床药代动力学
Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001.
本文引用的文献
1
Controlled trial of propranolol in thyrotoxicosis.普萘洛尔治疗甲状腺毒症的对照试验。
Lancet. 1969 May 17;1(7603):993-4. doi: 10.1016/s0140-6736(69)91797-8.
2
Thyroxine and triiodothyronine levels in hyperthyroid patients during treatment with propranolol.甲状腺功能亢进患者在使用普萘洛尔治疗期间的甲状腺素和三碘甲状腺原氨酸水平。
Clin Endocrinol (Oxf). 1977 Jul;7(1):41-4. doi: 10.1111/j.1365-2265.1977.tb02938.x.
3
Comparison of propranolol and practolol in the management of hyperthyroidism.普萘洛尔与心得宁治疗甲状腺功能亢进症的比较
Br J Clin Pharmacol. 1976 Apr;3(2):273-7. doi: 10.1111/j.1365-2125.1976.tb00603.x.
4
Subcellular distribution of thyroxine 5'-deiodinase in the rat kidney: a plasma membrane location.大鼠肾脏中甲状腺素5'-脱碘酶的亚细胞分布：定位于质膜
Endocrinology. 1978 Jul;103(1):274-80. doi: 10.1210/endo-103-1-274.
5
The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.
Clin Endocrinol (Oxf). 1978 Jul;9(1):67-72. doi: 10.1111/j.1365-2265.1978.tb03573.x.
6
Reduction of plasma triiodothyronine (T3) induced by propranolol.普萘洛尔诱导的血浆三碘甲状腺原氨酸（T3）降低。
Clin Endocrinol (Oxf). 1977 Jun;6(6):405-10. doi: 10.1111/j.1365-2265.1977.tb03322.x.
7
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.甲状腺功能亢进症患者在β-肾上腺素能阻滞剂治疗期间的血浆甲状腺素、3,3',5-三碘甲状腺原氨酸和3,3',5'-三碘甲状腺原氨酸
J Clin Endocrinol Metab. 1977 May;44(5):1002-5. doi: 10.1210/jcem-44-5-1002.
8
The formation of tri-iodothyronine and reverse tri-iodothyronine from thyroxine in isolated rat renal tubules.在分离的大鼠肾小管中由甲状腺素形成三碘甲状腺原氨酸和反式三碘甲状腺原氨酸。
Clin Sci Mol Med Suppl. 1978 Dec;55(6):567-72. doi: 10.1042/cs0550567.
9
Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kinetics.通过非房室动力学评估普萘洛尔对甲状腺素和3,3',5-三碘甲状腺原氨酸甲状腺外代谢的影响。
J Clin Endocrinol Metab. 1978 Sep;47(3):587-9. doi: 10.1210/jcem-47-3-587.
10
Subcellular localization of thyroxine and reverse triiodothyronine outer ring monodeiodinating activities.
Endocrinology. 1979 Feb;104(2):365-71. doi: 10.1210/endo-104-2-365.
Zotero 插件